Back to Neurology
Neurologyv2008Evidence-Based

HAT (Hemorrhage After Thrombolysis) Score for Predicting Post-tPA Hemorrhage

Predicts hemorrhage risk after tPA administration in acute ischemic stroke patients. Helps determine risk/benefit of tPA in borderline cases and identify patients needing closest monitoring.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
hat score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The HAT (Hemorrhage After Thrombolysis) Score for Predicting Post-tPA Hemorrhage is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within neurology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

HAT Score = Diabetes/Glucose (0-1) + NIHSS Score (0-2) + CT Hypodensity (0-2)

Clinical Pearls & Practice Notes

  • Symptomatic ICH defined as hemorrhage causing clinical deterioration
  • Score helps objectify tPA risk beyond clinical gestalt
  • Higher scores correlate with increased hemorrhage risk
  • If hemorrhage occurs: stop tPA, neurosurgical consult, consider hematology consult
  • Should not be used as sole criterion to withhold tPA in eligible patients

Evidence & Literature Citations

  1. Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008 Oct 28;71(18):1417-23. doi: 10.1212/01.wnl.0000330297.58334.dd.
  2. Tsivgoulis G, Frey JL, Flaster M, Sharma VK, Lao AY, Hoover SL, et al. Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage. Stroke. 2009 Nov;40(11):3631-4. doi: 10.1161/STROKEAHA.109.564096.
  3. Cucchiara B, Kasner SE, Tanne D, Levine SR, Demchuk A, Messe SR, et al. Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage. Int J Stroke. 2011 Apr;6(2):109-11. doi: 10.1111/j.1747-4949.2010.00555.x.

Score Interpretation Ranges

Low Risk0 – 0 pts

Low hemorrhage risk

Low-Moderate Risk1 – 1 pts

Low-moderate hemorrhage risk

Moderate Risk2 – 2 pts

Moderate hemorrhage risk

High Risk3 – 3 pts

High hemorrhage risk

Very High Risk4 – 5 pts

Very high hemorrhage risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.